Veradermics Inc. (MANE) Live Share Price, Invest From India

Veradermics Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$117.00
Day's Price Range
$127.90
$126.89
7.79%
Downside
0.80%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$126.89
100.00%
Downside
-100.00%
Upside

Veradermics Inc. share price movements today

Previous Close: $119.37
Open: $119.77
Volume: 1.3M
Day's Low - High: $117.00 - $127.90

Veradermics Inc. Historical Returns

1 Month Return: + 16.46 %
3 Month Return: + 76.71 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Veradermics Inc. Stock Fundamentals & Key Indicators

Check Veradermics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.9B

EPS (TTM)

-2.8122

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-72.06%

Veradermics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veradermics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Veradermics Inc.	NA	$4.9B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Indian Investors' Interest in Veradermics Inc. Stock

Search interest for Veradermics Inc. Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:-65% versus previous 30 day period

Veradermics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Mar 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-5	-12	-23	-29
EBITDA	-5	-	-21	-27
Interest Expense	0	-	0	-
Depreciation	-	-	-	-
Income Before Tax	-5	-12	-21	-27
Income Tax Expense	-	-	-	-
Net Income	-5	-12	-21	-27
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Veradermics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-17	-26	-72
EBITDA	-16	-25	-69
Interest Expense	0	0	-
Depreciation	-	-	-
Income Before Tax	-16	-26	-69
Income Tax Expense	-	-	-
Net Income	-16	-26	-69
Net Profit Margin	0.00%	0.00%	0.00%

Veradermics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2025	Dec 2025	Mar 2026
Net Income	-12	-21	-27
Operating Cash Flow	-13	-23	-21
Investing Cash Flow	-	-109	-101
Financing Cash Flow	8	149	269
Change in Cash	-20	16	146

Veradermics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-26	-69
Operating Cash Flow	-23	-71
Investing Cash Flow	-	-118
Financing Cash Flow	60	159
Change in Cash	36	-31

Global Institutional Holdings in Veradermics Inc.

Funds	Holdings
Vivo Capital, LLC	0.72%
FMR Inc	4.29%
JPMorgan Chase & Co	2.34%
Vanguard Capital Management, LLC	1.67%
Suvretta Capital Management, LLC	9.98%

See all

Insights on Veradermics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MANE stock has moved up by 35.2%

About Veradermics Inc.

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.

Organisation	Veradermics Inc.
Headquarters	470 James Street, New Haven, CT, United States, 06513
Industry	Biotechnology
CEO	Dr. Reid Waldman M.D.
E-voting on shares	Click here to vote

Key Management of Veradermics Inc.

Name	Title
Mr. Dominic Carrano CPA	CFO & Treasurer
Mr. Karl Pruss	Senior Director of Manufacturing Sciences & Technology
Mr. Mark Neumann	Chief Commercial & Strategy Officer
Ms. Erika Sipperly CPA	Controller
Dr. Michael Smolinski Ph.D.	Vice President of Development & Scientific Operations
Mr. Aron Shapiro	Vice President of Clinical Development & Regulatory Affairs
Dr. Reid Waldman M.D.	CEO & Director
Dr. Timothy Durso M.D.	Chief Technical Officer
Mr. Michael V. Greco J.D.	General Counsel & Secretary
Mr. Michael Murphy R.Ph.	VP of Project & Program Management of Business Technology and Chief of Staff

FAQs

What is Veradermics Inc. share price today?

Veradermics Inc. share price today is $126.89 as on June 27, 2026 at 8:45 am IST at the close of the market. Veradermics Inc. share today touched a day high of $127.9 and a low of $117.

What is the 52 week high and 52 week low for Veradermics Inc. share?

Veradermics Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Veradermics Inc. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $126.89,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Veradermics Inc.'s market capitalisation today?

Veradermics Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in Veradermics Inc. Stock (MANE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Veradermics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veradermics Inc. Shares that will get you 0.0118 shares as per Veradermics Inc. share price of $126.89 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Veradermics Inc. Stock (MANE) from India?

Indian investors can start investing in Veradermics Inc. (MANE) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Veradermics Inc. stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:40 am IST). Based on Veradermics Inc. share’s latest price of $126.89 as on June 27, 2026 at 8:45 am IST, you will get 0.0788 shares of Veradermics Inc.. Learn more about fractional shares .